Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing
Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways BEIJING, July 29, 2025 /PRNewswire/ — Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on July 26 in Beijing. The event convened over 100 leading scientists, biotech executives, and R&D […]
Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing Read Post »
Press







